Fingerprint
Dive into the research topics of 'Why is this effective HSP90 inhibitor not being developed in HER2+ breast cancer?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Why is this effective HSP90 inhibitor not being developed in HER2+ breast cancer?
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations